• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症可预测血液透析患者的全因死亡率和心血管死亡率。

Inflammation predicts all-cause and cardiovascular mortality in haemodialysis patients.

作者信息

Selim G, Stojceva-Taneva O, Zafirovska K, Sikole A, Gelev S, Dzekova P, Stefanovski K, Koloska V, Polenakovic M

机构信息

Department of Nephrology, Clinical Centre, Ss. Cyril and Methodius University, Skopje, R. Macedonia.

出版信息

Prilozi. 2006 Jul;27(1):133-44.

PMID:16985487
Abstract

Among non-traditional cardiovascular risk factors both malnutrition and inflammation appear to be strong predictors of mortality and morbidity in haemodialysis (HD) patients. Our study objective was to determine predictors of all-cause and cardiovascular mortality, considering the nutritional and immunologic parameters, in a cohort of HD patients treated in a single haemodialysis centre. 216 patients on HD were analyzed for clinical, nutritional-serum albumen and BMI, immunologic-serum CRP (C-reactive protein) and fibrinogen and dialysis parameters -- ultrafiltration, length of dialysis in hours, HD dose (using spKt/V and eKt/V). Mortality was monitored prospectively over a two-year period. Fifty-five of the 216 HD patients died during the follow-up period and the main cause of death was cardiovascular disease (CVD) -- 33 patients out of 55 (60%), followed by infection/sepsis (13 pts, 24%). The patients who died were significantly older, had a significantly shorter duration of HD in hours, ultrafiltration was significantly less, HD doses were significantly lower, as were serum levels of albumin (36.06 +/- 4.17 vs. 39.74 +/- 3.31; p=0.000) and Hg (93.14 +/- 15.43 vs. 109,16 +/- 12,08; p=0.000), but they had significantly higher serum levels of CRP (40.26 +/- 34.75 vs. 8.71 +/- 7.68, p=0.000) and fibrinogen (5.28 +/- 1.28 vs. 4.42 +/- 0.97, p=0.000). Kaplan-Meier survival estimates showed that the group with the lowest levels of albumin (< 3.5 g/L), and with the greatest levels of CRP (>20 mg/l) and fibrinogen (>5 g/L) had the lowest survival (log-rank test p=0.0008, p=0.00000, p=0.0000). However, in the Cox proportional hazards model, a high CRP and low Hg level (chi-square=96.467, p=0.0000) were predictors of all-cause mortality, whereas serum level of albumin did not show to be predictive. When only cardiovascular mortality is entered into the Cox model, CRP and Hg levels are still more important in predicting mortality (chi-square=70.055, p=0.0000) and only if CRP is not taken into account in the multivariate analysis, serum albumin level remains, after Hg, the strongest predictor for both overall and cardiovascular mortality (chi-square=76,564, p=0.0000; chi-square 50.619 p=0.0000). It can be concluded that inflammation predicted all-cause and cardiovascular mortality in our study group, because high CRP, as a marker of inflammation and low haemoglobin, as a result of inflammation, remained powerful predictors of both overall and cardiovascular death.

摘要

在非传统心血管危险因素中,营养不良和炎症似乎都是血液透析(HD)患者死亡率和发病率的有力预测因素。我们的研究目的是,在单个血液透析中心接受治疗的一组HD患者中,考虑营养和免疫参数,确定全因死亡率和心血管死亡率的预测因素。对216例HD患者进行了临床、营养指标(血清白蛋白和体重指数)、免疫指标(血清C反应蛋白(CRP)和纤维蛋白原)以及透析参数(超滤量、透析时长(小时)、HD剂量(使用标准化Kt/V和等效Kt/V))的分析。对患者进行了为期两年的前瞻性死亡监测。216例HD患者中有55例在随访期间死亡,主要死亡原因是心血管疾病(CVD)——55例中有33例(60%),其次是感染/脓毒症(13例,24%)。死亡患者年龄显著更大,HD时长(小时)显著更短,超滤量显著更少,HD剂量显著更低,血清白蛋白水平(36.06±4.17 vs. 39.74±3.31;p = 0.000)和血红蛋白水平(93.14±15.43 vs. 109.16±12.08;p = 0.000)也显著更低,但他们的血清CRP水平(40.26±34.75 vs. 8.71±7.68,p = 0.000)和纤维蛋白原水平(5.28±1.28 vs. 4.42±0.97,p = 0.000)显著更高。Kaplan-Meier生存估计显示,白蛋白水平最低(<3.5 g/L)、CRP水平最高(>20 mg/l)和纤维蛋白原水平最高(>5 g/L)的组生存率最低(对数秩检验p = 0.

相似文献

1
Inflammation predicts all-cause and cardiovascular mortality in haemodialysis patients.炎症可预测血液透析患者的全因死亡率和心血管死亡率。
Prilozi. 2006 Jul;27(1):133-44.
2
Association between haemoglobin level and all-cause mortality in haemodialysis patients: the link with inflammation and malnutrition.血液透析患者血红蛋白水平与全因死亡率之间的关联:与炎症和营养不良的联系。
Prilozi. 2007 Jul;28(1):81-95.
3
C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients.C反应蛋白可预测血液透析患者的全因死亡率和心血管死亡率。
Am J Kidney Dis. 2000 Mar;35(3):469-76. doi: 10.1016/s0272-6386(00)70200-9.
4
Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients.炎症、营养不良和心脏病作为血液透析患者死亡率的预测因素。
J Am Soc Nephrol. 2002 Jan;13 Suppl 1:S28-36.
5
Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.脑利钠肽在血液透析患者传统和非传统危险因素之间的作用:对两年随访中心血管死亡率的分析。
Nephron Clin Pract. 2011;119(2):c162-70. doi: 10.1159/000327615. Epub 2011 Jul 8.
6
Inflammation enhances cardiovascular risk and mortality in hemodialysis patients.炎症会增加血液透析患者的心血管风险及死亡率。
Kidney Int. 1999 Feb;55(2):648-58. doi: 10.1046/j.1523-1755.1999.00273.x.
7
[Nutritional status, comorbidity, and inflammation in hemodialysis].[血液透析中的营养状况、合并症和炎症]
Nefrologia. 2000 Nov-Dec;20(6):540-9.
8
Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.血液透析中的慢性炎症与死亡率:不同肾脏替代疗法的影响。RISCAVID研究结果
Nephrol Dial Transplant. 2008 Jul;23(7):2337-43. doi: 10.1093/ndt/gfm951. Epub 2008 Feb 27.
9
Inflammation and anaemia as predictors of cardiovascular mortality in hemodialysis patients.炎症和贫血作为血液透析患者心血管死亡的预测因素。
Hippokratia. 2007 Jan;11(1):39-43.
10
Inflammation and malnutrition as predictors of mortality in patients on hemodialysis.炎症和营养不良作为血液透析患者死亡率的预测因素。
J Nephrol. 2002 Mar-Apr;15(2):136-43.

引用本文的文献

1
Carnitine Supplementation in Chronic Hemodialysis Patients-A Literature Review.慢性血液透析患者补充肉碱——文献综述
J Clin Med. 2025 Jul 16;14(14):5052. doi: 10.3390/jcm14145052.
2
Impact of COVID-19 Vaccination on Cardiac Function and Survival in Maintenance Hemodialysis Patients.2019冠状病毒病疫苗接种对维持性血液透析患者心脏功能和生存的影响
Vaccines (Basel). 2025 Feb 20;13(3):208. doi: 10.3390/vaccines13030208.
3
Effectiveness of Lactoferrin in the Treatment of Anemia in Chronic Kidney Disease: A Single-Center Pilot Study.
乳铁蛋白治疗慢性肾脏病贫血的有效性:一项单中心试点研究。
Indian J Nephrol. 2024 May-Jun;34(3):222-227. doi: 10.4103/ijn.ijn_13_23. Epub 2023 Oct 23.
4
Potential Effects of Non-Surgical Periodontal Therapy on Periodontal Parameters, Inflammatory Markers, and Kidney Function Indicators in Chronic Kidney Disease Patients with Chronic Periodontitis.非手术牙周治疗对慢性牙周炎合并慢性肾脏病患者牙周参数、炎症标志物及肾功能指标的潜在影响
Biomedicines. 2022 Oct 29;10(11):2752. doi: 10.3390/biomedicines10112752.
5
Association of serum globulin with all-cause mortality in incident hemodialysis patients.血清球蛋白与新进入血液透析患者全因死亡率的相关性。
Nephrol Dial Transplant. 2022 Sep 22;37(10):1993-2003. doi: 10.1093/ndt/gfab292.
6
Active Smoking is Associated with Lower Dialysis Adequacy in Prevalent Dialysis Patients.主动吸烟与透析患者的透析充分性降低有关。
Open Access Maced J Med Sci. 2019 Nov 11;7(21):3615-3618. doi: 10.3889/oamjms.2019.851. eCollection 2019 Nov 15.
7
Level of inflammatory factors in chronic hemodialysis patients with and without cardiovascular disease.伴有和不伴有心血管疾病的慢性血液透析患者的炎症因子水平
J Res Med Sci. 2017 Apr 26;22:47. doi: 10.4103/jrms.JRMS_282_15. eCollection 2017.
8
Accelerated bone loss and increased post-fracture mortality in elderly women and men.老年女性和男性的骨质流失加速以及骨折后死亡率增加。
Osteoporos Int. 2015 Apr;26(4):1331-9. doi: 10.1007/s00198-014-3014-9. Epub 2015 Jan 20.
9
Cross-talk between endothelin-1 and mineral metabolism in hemodialysis patients: a cross-sectional study.血液透析患者中内皮素-1与矿物质代谢之间的相互作用:一项横断面研究。
Iran Red Crescent Med J. 2014 Jun;16(6):e18115. doi: 10.5812/ircmj.18115. Epub 2014 Jun 5.
10
Antihypertensive pharmacogenetic effect of fibrinogen-beta variant -455G>A on cardiovascular disease, end-stage renal disease, and mortality: the GenHAT study.纤维蛋白原β基因变体-455G>A对心血管疾病、终末期肾病及死亡率的降压药物遗传学效应:基因高血压治疗(GenHAT)研究
Pharmacogenet Genomics. 2009 Jun;19(6):415-21. doi: 10.1097/FPC.0b013e32832a8e81.